136 related articles for article (PubMed ID: 18572308)
1. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.
Taylor JL; Szmulewitz RZ; Lotan T; Hickson J; Griend DV; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Lett; 2008 Dec; 272(1):12-22. PubMed ID: 18572308
[TBL] [Abstract][Full Text] [Related]
2. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
[TBL] [Abstract][Full Text] [Related]
3. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
[TBL] [Abstract][Full Text] [Related]
4. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.
Robinson VL; Shalhav O; Otto K; Kawai T; Gorospe M; Rinker-Schaeffer CW
Mol Cancer Res; 2008 Mar; 6(3):501-8. PubMed ID: 18337456
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
[TBL] [Abstract][Full Text] [Related]
7. Role of mitogen-activated protein kinase kinase 4 in cancer.
Whitmarsh AJ; Davis RJ
Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Sec8 enhances the binding affinity of c-Jun N-terminal kinase (JNK)-interacting protein 4 for mitogen-activated protein kinase kinase 4 (MKK4) and suppresses the phosphorylation of MKK4, p38, and JNK, thereby inhibiting apoptosis.
Tanaka T; Iino M; Goto K
FEBS J; 2014 Dec; 281(23):5237-50. PubMed ID: 25244576
[TBL] [Abstract][Full Text] [Related]
9. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
[TBL] [Abstract][Full Text] [Related]
10. MKK4 Inhibitors-Recent Development Status and Therapeutic Potential.
Katzengruber L; Sander P; Laufer S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108658
[TBL] [Abstract][Full Text] [Related]
11. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway.
Guan Z; Buckman SY; Pentland AP; Templeton DJ; Morrison AR
J Biol Chem; 1998 May; 273(21):12901-8. PubMed ID: 9582321
[TBL] [Abstract][Full Text] [Related]
12. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
13. Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells.
Cazillis M; Bringuier AF; Delautier D; Buisine M; Bernuau D; Gespach C; Groyer A
Oncogene; 2004 Jun; 23(27):4735-44. PubMed ID: 15122334
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase.
Wu Z; Wu J; Jacinto E; Karin M
Mol Cell Biol; 1997 Dec; 17(12):7407-16. PubMed ID: 9372971
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
Kim HL; Vander Griend DJ; Yang X; Benson DA; Dubauskas Z; Yoshida BA; Chekmareva MA; Ichikawa Y; Sokoloff MH; Zhan P; Karrison T; Lin A; Stadler WM; Ichikawa T; Rubin MA; Rinker-Schaeffer CW
Cancer Res; 2001 Apr; 61(7):2833-7. PubMed ID: 11306453
[TBL] [Abstract][Full Text] [Related]
16. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.
Robinson VL; Hickson JA; Vander Griend DJ; Dubauskas Z; Rinker-Schaeffer CW
Clin Exp Metastasis; 2003; 20(1):25-30. PubMed ID: 12650604
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity.
Yang D; Tournier C; Wysk M; Lu HT; Xu J; Davis RJ; Flavell RA
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3004-9. PubMed ID: 9096336
[TBL] [Abstract][Full Text] [Related]
18. Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation.
Nakagawa K; Sugahara M; Yamasaki T; Kajiho H; Takahashi S; Hirayama J; Minami Y; Ohta Y; Watanabe T; Hata Y; Katada T; Nishina H
Biochem J; 2010 Mar; 427(2):237-45. PubMed ID: 20156194
[TBL] [Abstract][Full Text] [Related]
19. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.
Szmulewitz RZ; Clark R; Lotan T; Otto K; Taylor Veneris J; Macleod K; Rinker-Schaeffer C
Int J Cancer; 2012 Feb; 130(3):509-20. PubMed ID: 21351092
[TBL] [Abstract][Full Text] [Related]
20. Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions.
Shen CP; Tsimberg Y; Salvadore C; Meller E
BMC Neurosci; 2004 Sep; 5():36. PubMed ID: 15380027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
